Skip to Main Content

Paper Details

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components.
Onco Targets Ther
12
2022
PARP, PARPi, Poly(ADP-ribose), Poly(ADP-ribose) polymerase, homologous recombination repair deficiencies, patients
Author NameAffiliation
James H DoroshowNational Cancer Institute, National Institutes of Health
James H DoroshowNational Cancer Institute, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2